|Day Low/High||52.00 / 53.86|
|52 Wk Low/High||24.87 / 129.71|
The AZN affair exposes the seedy underbelly of drug manufacturing, and the COVID-19 vaccine is certainly a drug.
Let's look at the cold, hard facts around the vaccine rollout.
Stocks of companies that have Covid-19 vaccine candidates have boomed while those in the treatment space have not.
Make sure that your portfolio is composed of sane assets for the balance of this crazy year.
Experts pick their favorite long-term investments in medical diagnostics, testing and laboratory services.
When I first started buying ARCT shares I didn't conceive of a valuation of $1 billion, but I also didn't conceive of the global impact of a pandemic.
GE's problem can be summarized in one sentence: The company is burning cash.